BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12402583)

  • 1. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE; Leander M; Mariak I
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
    Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short peritoneal equilibration test: impact of preceding dwell time.
    Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
    Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children.
    Schaefer F; Langenbeck D; Heckert KH; Schärer K; Mehls O
    Adv Perit Dial; 1992; 8():410-5. PubMed ID: 1361835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T; Patlak CS
    Adv Perit Dial; 1995; 11():63-6. PubMed ID: 8534740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
    Hung SY; Chung HM
    Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years on continuous ambulatory peritoneal dialysis--does it change peritoneal transport?
    Kaczmarek EE; Grzegorzewska AE
    Adv Perit Dial; 2004; 20():2-7. PubMed ID: 15384785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the preceding exchange on peritoneal equilibration test results.
    Figueiredo AE; Conti A; Poli de Figueiredo CE
    Adv Perit Dial; 2002; 18():75-7. PubMed ID: 12402592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of peritoneal equilibration test (PET) in rats.
    Wieczorowska K; Khanna R; Moore HL; Nolph KD; Twardowski ZJ
    Adv Perit Dial; 1994; 10():33-7. PubMed ID: 7999859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the peritoneal equilibration test in pediatric dialysis patients.
    Ellis EN; Watts K; Wells TG; Arnold WC
    Adv Perit Dial; 1991; 7():259-61. PubMed ID: 1680439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of peritoneal equilibration test in children on continuous peritoneal dialysis by repeated testing with solutions of different osmolarity.
    Laux C; Bonzel KE; Rubbert-Lauterbach F; Büscher R; Wingen AM
    Adv Perit Dial; 1997; 13():263-6. PubMed ID: 9360695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
    Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
    Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy and nutrition in pediatric peritoneal dialysis.
    Cano FJ; Marín VS; Azocar MA; Delucchi MA; Rodriguez EE; Diaz ED; Villegas RC
    Adv Perit Dial; 2003; 19():273-8. PubMed ID: 14763078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.